Valneva SE (VALN) Non-Current Deffered Revenue (2021 - 2026)

Valneva SE's (VALN) quarterly Non-Current Deffered Revenue came in at $499908.4 in Q1 2026, down 87.33% year-on-year from $3.9 million in Q1 2025, and down 0.59% quarter-over-quarter from $502866.8 in Q4 2025.

Valneva SE (VALN) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Non-Current Deffered Revenue across 6 years of filings, most recently posting $499908.4 for Q1 2026.

  • Non-Current Deffered Revenue for Q1 2026 came in at $499908.4, down 87.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $499908.4 (down 87.33% YoY), and the FY2025 annual result was $502866.8, down 84.37% from the prior year.
  • Non-Current Deffered Revenue came in at $499908.4 for Q1 2026 at Valneva SE, down from $502866.8 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $137.5 million in Q1 2022 to a low of $494510.3 in Q3 2025.
  • The 5-year median for Non-Current Deffered Revenue is $5.7 million (2024), against an average of $20.4 million.
  • Peak annual rise in Non-Current Deffered Revenue reached 108.6% in 2023, while the deepest fall reached 92.85% in 2023.
  • Valneva SE's Non-Current Deffered Revenue stood at $9.6 million in 2022, then sank by 36.16% to $6.1 million in 2023, then slumped by 47.53% to $3.2 million in 2024, then tumbled by 84.37% to $502866.8 in 2025, then decreased by 0.59% to $499908.4 in 2026.
  • The last three Non-Current Deffered Revenue figures came in at $499908.4 (Q1 2026), $502866.8 (Q4 2025), and $494510.3 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn 499,908.39

Historic Data

Download Data
DateValue
Mar 31, 2026 499,908.39
Dec 31, 2025 502,866.80
Sep 30, 2025 494,510.30
Jun 30, 2025 588,619.04
Mar 31, 2025 3.95 Mn
Dec 31, 2024 3.22 Mn
Sep 30, 2024 1.05 Mn
Jun 30, 2024 5.71 Mn
Mar 31, 2024 5.75 Mn
Dec 31, 2023 6.13 Mn
Sep 30, 2023 14.53 Mn
Jun 30, 2023 12.61 Mn
Mar 31, 2023 9.83 Mn
Dec 31, 2022 9.60 Mn
Sep 30, 2022 6.96 Mn
Jun 30, 2022 127.74 Mn
Mar 31, 2022 137.46 Mn
Dec 31, 2021 5.42 Mn